Atg13 Activators

ATG13 activators constitute a class of chemical compounds that can induce the activation of ATG13 indirectly through their influence on autophagic pathways. ATG13 plays a pivotal role in the autophagy process, a fundamental cellular mechanism for maintaining homeostasis through the degradation and recycling of cellular components.

One prominent group of ATG13 activators includes mTOR inhibitors like rapamycin, torin 1, and everolimus. These compounds inhibit mTORC1, a negative regulator of autophagy, consequently releasing the inhibitory effect on ATG13, which can then participate in autophagosome formation. Resveratrol and metformin, on the other hand, activate autophagy through modulation of AMPK and SIRT1 signaling pathways, indirectly impacting ATG13 by engaging in upstream signaling events. Similarly, chemicals like AICAR, Spautin-1, and spermidine, by either mimicking AMP or regulating the deubiquitinase activity of key proteins, can initiate autophagy, potentially leading to ATG13 activation. Chloroquine and bafilomycin A1 interfere with lysosomal function, resulting in the accumulation of autophagosomes and autophagy induction, which indirectly activates ATG13. Trehalose stabilizes lysosomal membranes, facilitating autophagy, and influencing ATG13. Finally, tunicamycin induces ER stress, subsequently promoting autophagy, which can indirectly affect ATG13 activation.